Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012-2016.

Martin I, Sawatzky P, Allen V, Lefebvre B, Hoang L, Naidu P, Minion J, Van Caeseele P, Haldane D, Gad RR, Zahariadis G, Corriveau A, German G, Tomas K, Mulvey MR.

Can Commun Dis Rep. 2019 Feb 7;45(2-3):45-53. doi: 10.14745/ccdr.v45i23a01. eCollection 2019 Feb 7.

2.

Quality assurance for antimicrobial susceptibility testing of Neisseria gonorrhoeae in Latin American and Caribbean countries, 2013-2015.

Sawatzky P, Martin I, Galarza P, Carvallo MET, Araya Rodriguez P, Cruz OMS, Hernandez AL, Martinez MF, Borthagaray G, Payares D, Moreno JE, Chiappe M, Corredor AH, Thakur SD, Dillon JR.

Sex Transm Infect. 2018 Nov;94(7):479-482. doi: 10.1136/sextrans-2017-053502. Epub 2018 Apr 19.

PMID:
29674407
3.

Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.

Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Drews S, Horsman G, Wylie J, Haldane D, Garceau R, Ratnam S, Wong T, Archibald C, Mulvey MR.

Emerg Infect Dis. 2016 Jan;22(1):65-7. doi: 10.3201/eid2201.151247.

4.

Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012.

Sawatzky P, Liu G, Dillon JA, Allen V, Lefebvre B, Hoang L, Tyrrell G, Van Caeseele P, Levett P, Martin I.

J Clin Microbiol. 2015 Nov;53(11):3646-9. doi: 10.1128/JCM.02303-15. Epub 2015 Sep 2.

5.

Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2009-2013.

Martin I, Sawatzky P, Liu G, Mulvey MR.

Can Commun Dis Rep. 2015 Feb 5;41(2):35-41. eCollection 2015 Feb 5.

6.

Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010.

Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Lovgren M, Haldane D, Caeseele PV, Horsman G, Garceau R, Ratnam S, Wong T, Gilmour M.

Can J Microbiol. 2013 Oct;59(10):671-8. doi: 10.1139/cjm-2013-0357. Epub 2013 Aug 27.

PMID:
24102220
7.

Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.

Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, Gilmour M.

Sex Transm Dis. 2012 Apr;39(4):316-23. doi: 10.1097/OLQ.0b013e3182401b69.

PMID:
22421701
8.

Identification of prolyliminopeptidase-negative Neisseria gonorrhoeae strains in Canada.

Martin IE, Lefebvre B, Sawatzky P, Hoang L, Van Caeseele P, Horsman G, Ang L, Bourgault AM, Ng LK.

Sex Transm Dis. 2011 Jan;38(1):40-2. doi: 10.1097/OLQ.0b013e3181ebd524.

PMID:
20661175
9.

Serological diagnosis of syphilis: enzyme-linked immunosorbent assay to measure antibodies to individual recombinant Treponema pallidum antigens.

Martin IE, Lau A, Sawatzky P, Tsang RS, Cuff W, Lee C, Macpherson PA, Mazzulli T.

J Immunoassay Immunochem. 2008;29(2):143-51. doi: 10.1080/15321810801887771.

PMID:
18360809
10.
11.

Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin?

Ng LK, Sawatzky P, Galas M, Rodrigues Ddos P, Heitmann I, Fernandez S, Bolmström A.

Antimicrob Agents Chemother. 2003 Apr;47(4):1479-80. No abstract available.

12.

Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.

Ng LK, Sawatzky P, Martin IE, Booth S.

Sex Transm Dis. 2002 Dec;29(12):780-8.

PMID:
12466720

Supplemental Content

Loading ...
Support Center